Summary & Overview
HCPCS P9048: Infusion of Plasma Protein Fraction (Human) 5%, 250 ml
HCPCS Level II code P9048 denotes an infusion of plasma protein fraction (human), 5%, in a 250 ml volume. This biologic-derived intravenous fluid is used in clinical settings for plasma volume expansion and related supportive care. Nationally, accurate coding for P9048 is important for consistent clinical documentation, appropriate billing, and oversight of utilization for plasma-derived therapies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication reviews payer coverage scope, coding benchmarks, and common billing practices to help stakeholders understand how P9048 is processed across major payers. Where payer-specific details are not provided, the summary notes that input data was unavailable.
Readers will learn the clinical context of the product, the typical sites where the infusion is administered, and what to expect in payer coverage considerations. The piece highlights benchmark topics such as coding specificity, infusion setting implications for reimbursement, and documentation elements that typically accompany plasma protein fraction infusions. Data not available in the input is explicitly noted and not inferred.
Billing Code Overview
HCPCS Level II code P9048 represents infusion of plasma protein fraction (human), 5%, 250 ml. This service is an intravenous therapeutic infusion of a human-derived plasma protein solution at a 5% concentration provided in a 250 ml container.
-
Service type: Infusion therapy
-
Typical site of service: Infusion center, hospital outpatient department, or physician office where intravenous infusions are administered
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with chronic liver disease and hypoalbuminemia is admitted to an acute care hospital for management of refractory ascites and low serum albumin (albumin <2.5 g/dL) complicated by hypotension during large-volume paracentesis. The treating team orders a 250 mL infusion of plasma protein fraction (human) 5% (P9048) to restore intravascular oncotic pressure and support hemodynamics. Treatment is administered in an inpatient infusion suite or hospital ward by an infusion nurse under physician supervision. Pre-infusion steps include verification of physician order, review of allergies and prior reactions, baseline vital signs, assessment of fluid status, and informed consent documentation. During infusion, vital signs and infusion site are monitored; any adverse reactions (e.g., hypersensitivity, volume overload) are documented and managed per protocol. Post-infusion documentation includes volume infused, lot number, start/stop times, patient response, and updated orders for subsequent doses if indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no special circumstances apply and payer does not require a specific modifier. |
22 |